JACC in a Flash
Featured topics and Editors' Picks from all of ACC's JACC Journals.
The multicenter Hispanic Community Health Study/Study of Latinos (HCHS SOL), initiated by the National Heart, Lung, and Blood Institute in 2006, is the largest and most comprehensive, longitudinal community-based cohort study to date of diverse Hispanic/Latino persons in the U.S. Current findings from the main study and from some of the numerous ancillary studies, along with a description of the objectives of the study, were published in JACC.
National data suggest persistent disparities in women and underrepresented minorities in medicine (URMM) in pediatric cardiology programs in the U.S., according to a study published in JACC.
The absolute benefits of the SGLT2 inhibitor dapagliflozin is greater in Black patients in part due to having a higher incidence and prevalence of heart failure (HF), but the relative benefits are consistent in both Black and White patients, according to a study published in JACC: Heart Failure.
Statin therapy does not exacerbate muscle injury, pain or fatigue in people engaging in moderate-intensity exercise, such as walking, according to a study published in JACC.
Addressing social determinants of health (SDOH) is a key step in achieving equity in cardiovascular care, requiring investment by health systems, locally tailored plans and resources, and SDOH data "to anticipate patient needs and close care gaps," according to a JACC State-of-the-Art Review.
Clinical Topics: Dyslipidemia, Heart Failure and Cardiomyopathies, Nonstatins, Novel Agents, Statins, Acute Heart Failure
Keywords: ACC Publications, Cardiology Magazine, Cardiovascular Diseases, Heart Disease Risk Factors, Hispanic Americans, Obesity, Fellowships and Scholarships, Leadership, Workforce, Cardiology, Faculty, Cultural Diversity, Social Inclusion, Health Equity, Myalgia, Myalgia, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Economic Status, Built Environment, Heart Failure, Sodium-Glucose Transporter 2 Inhibitors, Stroke Volume, Stroke Volume, Ventricular Dysfunction, Left
< Back to Listings